| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Microbiology and Molecular Genetics, University of California, Los Angeles, CA 90095
Autoimmune diseases can result from the breakdown of regulation and subsequent activation of self-antigenic determinant-reactive T cells. During the evolution of the autoimmune response to myelin basic protein (MBP) in B10.PL mice, several distinct T cell populations expand: the effectors mediating experimental autoimmune encephalomyelitis (EAE) are MBP-reactive, CD4+, and predominantly TCR Vß8.2+; in addition, at least two regulatory populations can be detected—one comprised of Vß14+ CD4 T cells, reactive to a framework region 3 determinant on the Vß8.2 chain, and a second that is CD8+ and reactive to another Vß8.2 determinant. The combined action of these two regulatory cell types controls disease-causing effectors, resulting in spontaneous recovery from disease. In this report, we reveal that the cytokine secretion pattern of TCR peptide-specific regulatory CD4 T cells can profoundly influence whether a type 1 or type 2 population predominates among MBP-specific CD4 effectors. The priming of type 1 regulatory T cells results in deviation of the Ag-specific effector T cell population in a type 2 direction and protection from disease. In contrast, induction of type 2 regulatory T cells results in exacerbation of EAE, poor recovery, and an increased frequency of type 1 effectors. Thus, the encephalitogenic potential of the MBP-reactive effector population is crucially and dominantly influenced by the cytokine secretion phenotype of regulatory CD4 T cells. These findings have important implications in understanding peripheral tolerance to self-Ags as well as in the design of TCR-based therapeutic approaches.
This article has been cited by other articles:
|
|
 |
|
  L. T. Madakamutil, I. Maricic, E. E. Sercarz, and V. Kumar Immunodominance in the TCR Repertoire of {alpha}TCR Peptide-Specific CD4+ Treg Population That Controls Experimental Autoimmune Encephalomyelitis J. Immunol., April 1, 2008; 180(7): 4577 - 4585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Tang, I. Maricic, and V. Kumar Anti-TCR Antibody Treatment Activates a Novel Population of Nonintestinal CD8{alpha}{alpha}+TCR{alpha}beta+ Regulatory T Cells and Prevents Experimental Autoimmune Encephalomyelitis J. Immunol., May 15, 2007; 178(10): 6043 - 6050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nagato, H. Kobayashi, M. Yanai, K. Sato, N. Aoki, K. Oikawa, S. Kimura, Y. Abe, E. Celis, Y. Harabuchi, et al. Functional Analysis of Birch Pollen Allergen Bet v 1-Specific Regulatory T Cells J. Immunol., January 15, 2007; 178(2): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Tang, I. Maricic, N. Purohit, B. Bakamjian, L. M. Reed-Loisel, T. Beeston, P. Jensen, and V. Kumar Regulation of Immunity by a Novel Population of Qa-1-Restricted CD8{alpha}{alpha}+TCR{alpha}beta+ T Cells J. Immunol., December 1, 2006; 177(11): 7645 - 7655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Olcott, J. Tian, V. Walker, H. Dang, B. Middleton, L. Adorini, L. Washburn, and D. L. Kaufman Antigen-Based Therapies Using Ignored Determinants of {beta} Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice J. Immunol., August 1, 2005; 175(3): 1991 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Voo, G. Peng, Z. Guo, T. Fu, Y. Li, L. Frappier, and R.-F. Wang Functional Characterization of EBV-Encoded Nuclear Antigen 1-Specific CD4+ Helper and Regulatory T Cells Elicited by In vitro Peptide Stimulation Cancer Res., February 15, 2005; 65(4): 1577 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Wensky, G. C. Furtado, M. C. Garibaldi Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille IFN-{gamma} Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis J. Immunol., February 1, 2005; 174(3): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Honda, A. Ametani, T. Matsumoto, A. Iwaya, H. Kano, S. Hachimura, K. Ohkawa, S. Kaminogawa, K. Suzuki, E. E. Sercarz, et al. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis Int. Immunol., May 1, 2004; 16(5): 737 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Madakamutil, I. Maricic, E. Sercarz, and V. Kumar Regulatory T Cells Control Autoimmunity In Vivo by Inducing Apoptotic Depletion of Activated Pathogenic Lymphocytes J. Immunol., March 15, 2003; 170(6): 2985 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Braciak, B. Pedersen, J. Chin, C. Hsiao, E. S. Ward, I. Maricic, A. Jahng, F. L. Graham, J. Gauldie, E. E. Sercarz, et al. Protection Against Experimental Autoimmune Encephalomyelitis Generated by a Recombinant Adenovirus Vector Expressing the V{beta}8.2 TCR Is Disrupted by Coadministration with Vectors Expressing Either IL-4 or -10 J. Immunol., January 15, 2003; 170(2): 765 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Jahng, I. Maricic, B. Pedersen, N. Burdin, O. Naidenko, M. Kronenberg, Y. Koezuka, and V. Kumar Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis J. Exp. Med., December 17, 2001; 194(12): 1789 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Sorensen and F. Sellebjerg Distinct chemokine receptor and cytokine expression profile in secondary progressive MS Neurology, October 23, 2001; 57(8): 1371 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Cunningham Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis Am. J. Pathol., July 1, 2001; 159(1): 5 - 12. [Full Text] [PDF]
|
|
|
|
|
|
V. Kumar, J. Maglione, J. Thatte, B. Pederson, E. Sercarz, and E. S. Ward Induction of a type 1 regulatory CD4 T cell response following V{beta}8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis Int. Immunol., June 1, 2001; 13(6): 835 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quinn, B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, and E. E. Sercarz Regulatory and Effector CD4 T Cells in Nonobese Diabetic Mice Recognize Overlapping Determinants on Glutamic Acid Decarboxylase and Use Distinct V{{beta}} Genes J. Immunol., March 1, 2001; 166(5): 2982 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Huang, P. A. MacAry, P. Eynott, A. Moussavi, K. C. Daniel, P. W. Askenase, D. M. Kemeny, and K. F. Chung Allergen-Specific Th1 Cells Counteract Efferent Th2 Cell-Dependent Bronchial Hyperresponsiveness and Eosinophilic Inflammation Partly Via IFN-{{gamma}} J. Immunol., January 1, 2001; 166(1): 207 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. E. van Tienhoven, C. P. M. Broeren, A. Noordzij, J. P. A. Wagenaar, W. van Eden, and M. H. M. Wauben Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis Int. Immunol., December 1, 2000; 12(12): 1715 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Costa, J. M. Benson, C. M. Seroogy, P. Achacoso, C. G. Fathman, and G. P. Nolan Targeting Rare Populations of Murine Antigen-Specific T Lymphocytes by Retroviral Transduction for Potential Application in Gene Therapy for Autoimmune Disease J. Immunol., April 1, 2000; 164(7): 3581 - 3590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Suzuki, Y. W. Zhou, M. Kato, T. W. Mak, and I. Nakashima Normal Regulatory {alpha}/{beta} T Cells Effectively Eliminate Abnormally Activated T Cells Lacking the Interleukin 2 Receptor {beta} In Vivo J. Exp. Med., December 6, 1999; 190(11): 1561 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lobell, R. Weissert, S. Eltayeb, C. Svanholm, T. Olsson, and H. Wigzell Presence of CpG DNA and the Local Cytokine Milieu Determine the Efficacy of Suppressive DNA Vaccination in Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 1999; 163(9): 4754 - 4762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Falcone, B. Yeung, L. Tucker, E. Rodriguez, and N. Sarvetnick A Defect in Interleukin 12–induced Activation and Interferon {gamma} Secretion of Peripheral Natural Killer T Cells in Nonobese Diabetic Mice Suggests New Pathogenic Mechanisms for Insulin-dependent Diabetes Mellitus J. Exp. Med., October 4, 1999; 190(7): 963 - 972. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
